Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00692692 · ClinicalTrials.gov registry record · NA
Use of Dermal Matrix in Breast Reconstruction
A NA study, sponsored by Vanderbilt University.
- Terminated
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT00692692 is a NA study that was terminated before completion, run by Vanderbilt University. The registered enrollment target is 36 participants.
The verdict
NCT00692692, a NA study, was terminated before completion, sponsored by Vanderbilt University.
- TERMINATED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
We propose to evaluate the question of whether there is a significant difference between the traditional method of serratus flap tissue expander reconstruction and the acellular matrix method.
Interventions
- PROCEDURE DermaMatrix
- PROCEDURE standard of care tissue expander breast reconstruction surgery after mastectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2007-06 |
| Est. Completion | 2010-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00692692
The ClinicalTrials.gov registry entry for NCT00692692 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which DermaMatrix is the first listed.
NCT00692692 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00692692 about?
NCT00692692 is a clinical study titled "Use of Dermal Matrix in Breast Reconstruction". We propose to evaluate the question of whether there is a significant difference between the traditional method of serratus flap tissue expander reconstruction and the acellular matrix method.
What is the current status of trial NCT00692692?
This trial is currently terminated. It is a NA study. The enrollment target is 36 participants. The study started on 2007-06. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00692692?
The interventions under investigation include: DermaMatrix (PROCEDURE), standard of care tissue expander breast reconstruction surgery after mastectomy (PROCEDURE).
Who is sponsoring clinical trial NCT00692692?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.